CI
Cytokinetics Inc
🇩🇪XSTU.KK3AGermanyHealthcare
€60.36EURup +0.54 (+0.9%)OpenEnd of day6:24 AM
Price€60.36+0.54 (+0.9%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US23282W6057
- CUSIP
- Not reported
Company
- Employees
- 673
- Headquarters
- South San Francisco, United States
- Website
- https://www.cytokinetics.com
- CEO
- Mr. Robert I. Blum
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$6.77
- P/E LTM
- -12.76
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $70.96M-17.24%down year on year
- Net income
- -$894M-47.45%down year on year
- Gross margin
- 84.97%+137.43%up year on year
- Free cash flow
- -$580.71M-31.84%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.